Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $85.9700 (0.21%) ($84.5400 - $87.0600) on Fri. Feb. 12, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.83% (three month average) | RSI | 29 | Latest Price | $85.9700(0.21%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1.5% a day on average for past five trading days. | Weekly Trend | LGND declines -6.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(56%) XBI(56%) IWM(52%) ARKG(51%) | Factors Impacting LGND price | LGND will decline at least -1.415% in a week (0% probabilities). VIXM(-16%) TLT(-16%) UUP(-7%) GDXJ(-6%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.415% (StdDev 2.83%) | Hourly BBV | 0 () | Intraday Trend | -0.9% | | | |
|
1 - 5 Day Possible Target | $79.04(-8.06%) | Resistance Level | $96.03 | 5 Day Moving Average | $87.68(-1.95%) | 10 Day Moving Average | $92.72(-7.28%) | 20 Day Moving Average | $96.03(-10.48%) | To recent high | -23.1% | To recent low | 0.2% | Market Cap | $1.382b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |